Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

Author： Nicolau David P  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.2, 2004-02, pp. : 229-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

By Yassin H.M.   Dever L.L.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 353-367

Informa Healthcare

Access to resources Recommend Favorite

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections

By Hammerschlag Margaret R   Sharma Roopali  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 387-400

Informa Healthcare

Access to resources Recommend Favorite

Moxifloxacin: A Review of its Clinical Potential in the Management of Community-Acquired Respiratory Tract Infections

By Barman Balfour J.A.   Lamb H.M.  

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 115-139

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Newer Oral Cephalosporins: Implications for Treatment of Community-Acquired Lower Respiratory Tract Infections

By Cazzola M.   Matera M.G.   Donner C.F.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 335-346

Adis International

Access to resources Recommend Favorite

What is the Place of Fluoroquinolones in the Treatment of Community-Acquired Respiratory Tract Infections?

By Momméja-Marin H.   Carbon C.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 851-853

Adis International

Access to resources Recommend Favorite